Sanofi (NASDAQ:SNY) Q4 2021 Results Conference Call February 4, 2022 7:30 AM ET
Company Participants
Eva Schaefer-Jansen - Head, IR
Paul Hudson - CEO
Bill Sibold - Global Business Unit Head
Thomas Triomphe - Global Business Unit Head
Olivier Charmeil - Global Business Unit Head
Julie Van Ongevalle - Global Business Unit Head
Jean-Baptiste de Chatillon - CFO
John Reed - EVP, Global Head of Research & Development
Conference Call Participants
Wimal Kapadia - Bernstein
Richard Vosser - JP Morgan
Luisa Hector - Berenberg
Simon Mather - Exane
Graham Parry - Bank of America
Tim Anderson - Wolfe
Mark Purcell - Morgan Stanley
Emmanuel Papadakis - Deutsche Bank
Jo Walton - Credit Suisse
Eva Schaefer-Jansen
Good morning, good afternoon, and good evening to everyone. Thank you for joining us to review Sanofi’s 2021 Fourth Quarter and Full Year Results followed by a Q&A session. As usual, you can find the slides to this earnings call on the Investors page of our website at sanofi.com.
Moving to slide 3, I would like to remind you that information presented in this call contains forward-looking statements that involve known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially. I refer you to our Form 20-F document on file with the SEC and also our Document d’Enregistrement Universal for a description of these risk factors. With that, please advance to slide 4.
Our speakers on the call today are Paul Hudson, Chief Executive Officer; the Global Business Unit Heads Bill Sibold, Thomas Triomphe, Olivier Charmeil, and Julie Van Ongevalle; and Jean-Baptiste de Chatillon, Chief Financial Officer.
For the Q&A, you have two options to participate. Option one, click the raise hand icon at the bottom of your screen or option two, submit your question by clicking the Q&A icon at the bottom
- Read more current SNY analysis and news
- View all earnings call transcripts